Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.36 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9019840 | 0.90 | HPGD (0.46) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL2464875 | 0.84 | PDE3A (0.50) | KMT2AMEN1TSHRHPGDKDM4E | |
| SCHEMBL2467673 | 0.84 | MEN1 (0.71) | KMT2AMEN1TSHRKDM4EGAA | |
| SCHEMBL8444827 | 0.83 | MEN1 (0.71) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL9540520 | 0.82 | HPGD (0.45) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL9538968 | 0.82 | HPGD (0.43) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL9538971 | 0.82 | HPGD (0.43) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL9540513 | 0.82 | HPGD (0.45) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL9538872 | 0.82 | HPGD (0.43) | KMT2AMEN1TSHRHPGDGDA | |
| SCHEMBL9540499 | 0.82 | HPGD (0.45) | KMT2AMEN1TSHRHPGDGDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112608313-B | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-112608313-A | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| EP-1565469-A1 | PROCESS FOR THE SYNTHESIS OF GANCICLOVIR | RANBAXY LABORATORIES, LTD. (IN) | 2005-08-24 | — | — | EP | claimed |
| WO-2004048380-A1 | PROCESS FOR THE SYNTHESIS OF GANCICLOVIR | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-10 | — | — | WO | claimed |
| EP-0532878-A2 | Process for producing acyclic nucleosides | Ajinomoto Co., Inc. (JP) | 1993-03-24 | — | — | EP | claimed |
| CN-112608313-B | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-112608313-B | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-112608313-A | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2021-04-06 | — | — | CN | disclosed |
| CN-112608313-A | Treatment method of mother liquor precipitate in production of triacetyl ganciclovir | 河北合佳医药科技集团股份有限公司 | 2021-04-06 | — | — | CN | disclosed |
| WO-2011114336-A1 | PROCESS FOR THE ISOLATION OF GANCICLOVIR INTERMEDIATE | HETERO RESEARCH FOUNDATION (IN) | 2011-09-22 | — | — | WO | disclosed |
| EP-1565469-A1 | PROCESS FOR THE SYNTHESIS OF GANCICLOVIR | RANBAXY LABORATORIES, LTD. (IN) | 2005-08-24 | — | — | EP | disclosed |
| EP-1453833-A2 | A PROCESS FOR THE PREPARATION OF GANCICLOVIR INTERMEDIATE N2-ACETYL-9-(1,3-DIACETOXY-2-PROPOXYMETHYL) GUANINE | RANBAXY LABORATORIES, LTD. (IN) | 2004-09-08 | — | — | EP | disclosed |
| WO-2004048380-A1 | PROCESS FOR THE SYNTHESIS OF GANCICLOVIR | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-10 | — | — | WO | disclosed |
| WO-2003033498-A2 | A PROCESS FOR THE TREATMENT OF GANCICLOVIR INTERMEDIATE N2-ACETYL-9-(1, 3-DIACETOXY-2-PROPOXYMETHYL) GUANINE | RANBAXY LABORATORIES LIMITED (IN) | 2003-04-24 | — | — | WO | disclosed |
| US-5583225-A | REACTING N2, N9-DIPROTECTED GUANINE WITH DIACETOXYPROPANE IN THE PRESENCE OF A MIXTURE OF AN ACID AND ACETIC ANHYDRIDE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1996-12-10 | — | — | US | disclosed |